BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 20800306)

  • 1. Relapsing features of bile salt export pump deficiency after liver transplantation in two patients with progressive familial intrahepatic cholestasis type 2.
    Maggiore G; Gonzales E; Sciveres M; Redon MJ; Grosse B; Stieger B; Davit-Spraul A; Fabre M; Jacquemin E
    J Hepatol; 2010 Nov; 53(5):981-6. PubMed ID: 20800306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history.
    Davit-Spraul A; Fabre M; Branchereau S; Baussan C; Gonzales E; Stieger B; Bernard O; Jacquemin E
    Hepatology; 2010 May; 51(5):1645-55. PubMed ID: 20232290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence of Progressive Familial Intrahepatic Cholestasis Type 2 Phenotype After Living-donor Liver Transplantation: A Case Report.
    Masahata K; Uehara S; Ibuka S; Nakahata K; Hasegawa Y; Kondou H; Kubitz R; Ueno T
    Transplant Proc; 2016 Nov; 48(9):3156-3162. PubMed ID: 27932171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholestasis After Pediatric Liver Transplantation-Recurrence of a Progressive Familial Intrahepatic Cholestasis Phenotype as a Rare Differential Diagnosis: A Case Report.
    Prusinskas B; Kathemann S; Pilic D; Hegen B; Küster P; Keitel V; Häussinger D; Büscher R; Baba HA; Hoyer PF; Lainka E
    Transplant Proc; 2017 Sep; 49(7):1628-1633. PubMed ID: 28838453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo bile salt transporter antibodies as a possible cause of recurrent graft failure after liver transplantation: a novel mechanism of cholestasis.
    Keitel V; Burdelski M; Vojnisek Z; Schmitt L; Häussinger D; Kubitz R
    Hepatology; 2009 Aug; 50(2):510-7. PubMed ID: 19642168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphologic findings in progressive familial intrahepatic cholestasis 2 (PFIC2): correlation with genetic and immunohistochemical studies.
    Evason K; Bove KE; Finegold MJ; Knisely AS; Rhee S; Rosenthal P; Miethke AG; Karpen SJ; Ferrell LD; Kim GE
    Am J Surg Pathol; 2011 May; 35(5):687-96. PubMed ID: 21490445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive familial intrahepatic cholestasis.
    Jacquemin E
    Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S26-35. PubMed ID: 23141890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mutation within a transmembrane helix of the bile salt export pump (BSEP, ABCB11) with delayed development of cirrhosis.
    Stindt J; Ellinger P; Weissenberger K; Dröge C; Herebian D; Mayatepek E; Homey B; Braun S; Schulte am Esch J; Horacek M; Canbay A; Schmitt L; Häussinger D; Kubitz R
    Liver Int; 2013 Nov; 33(10):1527-35. PubMed ID: 23758865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted pharmacotherapy in progressive familial intrahepatic cholestasis type 2: Evidence for improvement of cholestasis with 4-phenylbutyrate.
    Gonzales E; Grosse B; Schuller B; Davit-Spraul A; Conti F; Guettier C; Cassio D; Jacquemin E
    Hepatology; 2015 Aug; 62(2):558-66. PubMed ID: 25716872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful mutation-specific chaperone therapy with 4-phenylbutyrate in a child with progressive familial intrahepatic cholestasis type 2.
    Gonzales E; Grosse B; Cassio D; Davit-Spraul A; Fabre M; Jacquemin E
    J Hepatol; 2012 Sep; 57(3):695-8. PubMed ID: 22609309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical phenotype and molecular analysis of a homozygous ABCB11 mutation responsible for progressive infantile cholestasis.
    Imagawa K; Hayashi H; Sabu Y; Tanikawa K; Fujishiro J; Kajikawa D; Wada H; Kudo T; Kage M; Kusuhara H; Sumazaki R
    J Hum Genet; 2018 May; 63(5):569-577. PubMed ID: 29507376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial external biliary diversion in bile salt export pump deficiency: Association between outcome and mutation.
    Ellinger P; Stindt J; Dröge C; Sattler K; Stross C; Kluge S; Herebian D; Smits SHJ; Burdelski M; Schulz-Jürgensen S; Ballauff A; Schulte Am Esch J; Mayatepek E; Häussinger D; Kubitz R; Schmitt L
    World J Gastroenterol; 2017 Aug; 23(29):5295-5303. PubMed ID: 28839429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired expression and function of the bile salt export pump due to three novel ABCB11 mutations in intrahepatic cholestasis.
    Noe J; Kullak-Ublick GA; Jochum W; Stieger B; Kerb R; Haberl M; Müllhaupt B; Meier PJ; Pauli-Magnus C
    J Hepatol; 2005 Sep; 43(3):536-43. PubMed ID: 16039748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab as therapy for the recurrence of bile salt export pump deficiency after liver transplantation.
    Lin HC; Alvarez L; Laroche G; Melin-Aldana H; Pfeifer K; Schwarz K; Whitington PF; Alonso EM; Ekong UD
    Liver Transpl; 2013 Dec; 19(12):1403-10. PubMed ID: 24115678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bile salt export pump-reactive antibodies form a polyclonal, multi-inhibitory response in antibody-induced bile salt export pump deficiency.
    Stindt J; Kluge S; Dröge C; Keitel V; Stross C; Baumann U; Brinkert F; Dhawan A; Engelmann G; Ganschow R; Gerner P; Grabhorn E; Knisely AS; Noli KA; Pukite I; Shepherd RW; Ueno T; Schmitt L; Wiek C; Hanenberg H; Häussinger D; Kubitz R
    Hepatology; 2016 Feb; 63(2):524-37. PubMed ID: 26516723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune BSEP disease: disease recurrence after liver transplantation for progressive familial intrahepatic cholestasis.
    Kubitz R; Dröge C; Kluge S; Stross C; Walter N; Keitel V; Häussinger D; Stindt J
    Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):273-84. PubMed ID: 25342496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in bile salt export pump (ABCB11) in two children with progressive familial intrahepatic cholestasis and cholangiocarcinoma.
    Scheimann AO; Strautnieks SS; Knisely AS; Byrne JA; Thompson RJ; Finegold MJ
    J Pediatr; 2007 May; 150(5):556-9. PubMed ID: 17452236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive Familial Intrahepatic Cholestasis Type 2 and Recurrence After Liver Transplantation: A Case Report.
    Romeres SGB; Trevizoli NC; Oliveira CAM; Obeid EJ; Arantes Ferreira GS; De Campos PB; Ullmann RFB; Rocha HC; Figueira AVF; Diaz LGG; Jorge FMF; Caja GON; Watanabe ALC; Sobroza de Mello E; Carvalho E
    Transplant Proc; 2022 Jun; 54(5):1370-1375. PubMed ID: 35718560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-chain ubiquitination is associated with the degradation rate of a cell-surface-resident bile salt export pump (BSEP/ABCB11).
    Hayashi H; Sugiyama Y
    Mol Pharmacol; 2009 Jan; 75(1):143-50. PubMed ID: 18829893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis.
    Jansen PL; Strautnieks SS; Jacquemin E; Hadchouel M; Sokal EM; Hooiveld GJ; Koning JH; De Jager-Krikken A; Kuipers F; Stellaard F; Bijleveld CM; Gouw A; Van Goor H; Thompson RJ; Müller M
    Gastroenterology; 1999 Dec; 117(6):1370-9. PubMed ID: 10579978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.